Insights are trapped in mountains of text. NLP sets them free.
Director, IQVIA NLP, Safety & Regulatory
Safety in drug development is one of the biggest challenges and opportunities facing life sciences companies today. The rapidly increasing volume of safety reports and relevant documents is almost unsustainable for manual efforts, and pharma companies are looking for innovative AI technologies to bring significant process improvements.
Many of our customers use the power of IQVIA’s Natural Language Processing (NLP) platform to optimize their safety processes such as medical literature monitoring, to reduce costs and gain more value from the insights generated.
NLP is an AI technology that transforms unstructured text into structured data, enabling rapid review and analysis. This capability can be applied for safety assessment and medical review, providing effective search of literature, drug labels and regulatory review packages for adverse events and the critical context around these, to help with a deeper understanding and contextualization of any potential safety signal.
This webinar will present an overview of customer success stories, including use cases from the FDA, and a demo of IQVIA’s NLP Safety Intelligence Hub, to show how NLP can enable your team to advance drug safety.
What will you learn?
Informaticians, information professionals, researchers, with responsibility for:
Director, IQVIA NLP, Safety & Regulatory
Senior Application Scientist at IQVIA NLP
Insights are trapped in mountains of text. NLP sets them free.
IQVIA is using vast quantities of data in powerful new ways. See how we can help you tap into information from past trials, patient reported outcomes and other sources to accelerate your research.